+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cardiac Rehabilitation Device Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011204
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cardiac Rehabilitation Device Market is projected to reach USD 2.95 Billion in 2026. It is expected to continue growing at a CAGR of 8.50%, reaching USD 4.87 Billion by 2032.

Cardiac rehabilitation devices are moving from facility-only equipment to connected, data-generating platforms that support supervised exercise, rhythm monitoring, recovery tracking, and risk-factor management after myocardial infarction, revascularization, heart failure, or other cardiovascular events.

The clinical need is substantial. The World Health Organization identifies cardiovascular diseases as the leading cause of death worldwide, accounting for an estimated 17.9 million deaths annually. In the United States, the CDC reports about 805,000 heart attacks each year, underscoring the need for scalable secondary prevention. Evidence-based cardiac rehabilitation is associated with improved functional capacity, better medication adherence, and lower risk of rehospitalization, making devices that enable safe participation increasingly important to health systems and payers.

Transformative Shifts in the Cardiac Rehabilitation Device Landscape

The cardiac rehabilitation device landscape is being reshaped by hybrid care models, remote patient monitoring, and consumer-grade wearables connected to clinical workflows. Hospitals and rehabilitation centers continue to rely on ECG telemetry, ergometers, treadmills, blood pressure monitors, and pulse oximetry, while home-based programs increasingly use connected sensors, mobile applications, and cloud dashboards.

This shift is supported by public health priorities. The American Heart Association and major guideline bodies recognize cardiac rehabilitation as a core component of secondary prevention, yet participation remains below eligible-patient levels in many countries. Device makers are therefore competing on interoperability, patient engagement, reimbursement alignment, cybersecurity, and the ability to document measurable outcomes rather than on hardware performance alone.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is adding cumulative value across the cardiac rehabilitation device ecosystem by converting continuous streams of ECG, activity, heart-rate, blood pressure, and symptom data into actionable risk signals. AI-enabled analytics can support patient triage, personalize exercise intensity, identify adherence barriers, and flag patterns that may require clinician review.

The most credible near-term opportunity is decision support rather than autonomous care. FDA-cleared software functions, validated remote monitoring workflows, and transparent clinical governance are essential because cardiac rehabilitation patients often have complex comorbidities. Vendors that combine AI with explainability, cybersecurity, human oversight, and evidence generation will be better positioned than companies promoting unvalidated automation.

Key Regional Insights

North America remains a leading environment for cardiac rehabilitation device adoption because of mature hospital networks, high cardiovascular procedure volumes, digital health reimbursement pathways, and growing use of remote patient monitoring. The United States is particularly influential due to Medicare coverage for cardiac rehabilitation and intensive cardiac rehabilitation, while Canada benefits from provincial cardiac care programs and expanding virtual rehabilitation pilots.

Europe shows strong demand driven by guideline-based secondary prevention, aging populations, and structured rehabilitation pathways across Germany, France, Italy, Spain, and the United Kingdom. The European Union’s medical device regulatory framework raises evidence, clinical evaluation, and post-market surveillance expectations, which can increase compliance costs but also strengthens trust in clinically validated devices.

Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia address rising cardiovascular disease burden, urban lifestyle risk factors, aging demographics, and uneven access to specialist rehabilitation. Latin America, led by Brazil and Mexico, is gradually adopting connected rehabilitation models in private networks and tertiary hospitals as noncommunicable disease programs gain priority. The Middle East, particularly GCC markets, is investing in advanced cardiovascular care infrastructure and digital health platforms, while Africa presents long-term need for affordable, durable, and mobile-enabled cardiac rehabilitation solutions where access to center-based programs remains limited.

Key Group Insights

The G7 markets are central to premium cardiac rehabilitation device demand because they combine high cardiovascular procedure volumes, established reimbursement systems, advanced hospital infrastructure, and rigorous clinical evidence expectations. These countries also influence procurement standards for remote monitoring, cybersecurity, interoperability, and electronic health record integration.

The European Union is shaping the competitive environment through Medical Device Regulation requirements, data protection rules, and cross-border emphasis on evidence-based care. BRICS economies are important for broad adoption because of large patient populations, increasing hospital investment, and rising chronic disease burden, although affordability, reimbursement maturity, and specialist access vary widely across members.

ASEAN markets are advancing through private hospital expansion, medical tourism hubs, and government efforts to strengthen noncommunicable disease care. GCC countries are investing in advanced cardiology infrastructure and national digital health platforms, creating opportunities for connected rehabilitation systems. NATO countries overlap substantially with high-income markets where procurement increasingly weighs operational resilience, cybersecurity, supply chain transparency, and device compliance.

Key Country Insights

The United States leads in commercial opportunity due to Medicare-recognized cardiac rehabilitation coverage, large post-acute cardiovascular populations, and fast adoption of remote patient monitoring. Canada emphasizes equitable access across provinces and virtual care expansion, while Mexico and Brazil represent growing Latin American demand where private hospitals, tertiary cardiac centers, and urban care networks often lead adoption.

In Europe, the United Kingdom, Germany, France, Italy, and Spain offer strong clinical foundations for secondary prevention, but purchasing is shaped by national health budgets, health technology assessment, reimbursement rules, and regional service capacity. Russia has demand linked to cardiovascular burden and hospital modernization, though procurement complexity, localization requirements, and geopolitical factors affect supplier strategies.

China and India present major long-term volume opportunities because of large populations, expanding cardiology capacity, and rising cardiovascular risk, but success depends on cost-effective devices, local partnerships, and scalable training models. Japan, South Korea, and Australia favor clinically validated, connected rehabilitation systems aligned with aging populations, advanced cardiology care, strong digital health infrastructure, and high expectations for safety and evidence.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated connected devices that improve access without reducing safety. The strongest strategies combine ECG telemetry, activity monitoring, blood pressure tracking, pulse oximetry, patient education, and clinician dashboards into interoperable workflows that fit hospital, outpatient, and home-based cardiac rehabilitation.

Organizations should invest in randomized evidence, real-world outcomes, and health economic data showing reduced readmissions, improved functional capacity, higher adherence, and better program completion. Partnerships with cardiology groups, payers, rehabilitation networks, and digital health providers can accelerate adoption and support integration into secondary prevention pathways.

A resilient strategy should include cybersecurity-by-design, compliance with FDA and EU MDR expectations, multilingual patient engagement, accessible user interfaces, and tiered product models for high-income and cost-sensitive markets.

Research Methodology

This executive summary is developed from verified secondary research and market intelligence synthesis. Core sources include public health data from the World Health Organization and CDC, cardiovascular guidance from the American Heart Association and European cardiology organizations, regulatory information from the FDA and European Commission, and peer-reviewed evidence on cardiac rehabilitation outcomes.

The research approach evaluates clinical need, care delivery models, reimbursement signals, device categories, regional adoption factors, regulatory pathways, and technology trends. Insights are triangulated across epidemiology, policy, clinical guidelines, procurement behavior, digital health adoption, and published clinical evidence to ensure an evidence-based view of the cardiac rehabilitation device landscape.

Conclusion

The cardiac rehabilitation device landscape is gaining strategic importance as cardiovascular disease burden rises and health systems seek scalable secondary prevention. Demand is shifting toward connected, hybrid, and evidence-backed solutions that extend supervised rehabilitation beyond traditional facilities.

Successful participants will be those that prove clinical value, integrate seamlessly into care pathways, protect patient data, and support equitable access across regions. Artificial intelligence, remote monitoring, and interoperable platforms can accelerate transformation, but durable adoption will depend on validated outcomes, regulatory compliance, and trusted implementation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cardiac Rehabilitation Device Market, by Product Type
7.1. Introduction
7.2. Monitoring Devices
7.2.1. Blood Pressure Monitors
7.2.2. EcG Monitors
7.2.3. Multi-Parameter Monitors
7.2.4. Pulse Oximeters
7.3. Rehabilitation Equipment
7.3.1. Arm Ergometer
7.3.2. Cycle Ergometers
7.3.3. Treadmills
7.4. Therapeutic Devices
7.4.1. Electrical Stimulation Devices
7.4.2. Respiratory Therapy Devices
7.4.3. Ultrasound Therapy Devices
8. Cardiac Rehabilitation Device Market, by Clinical Indication
8.1. Introduction
8.2. Post-Myocardial Infarction
8.3. Heart Failure Rehabilitation
8.4. Post-Coronary Artery Bypass Graft
8.5. Post-Valve Replacement
9. Cardiac Rehabilitation Device Market, by End User
9.1. Introduction
9.2. Clinics
9.2.1. Cardiac Rehab Clinics
9.2.2. Physical Therapy Clinics
9.3. Home Care Settings
9.3.1. Caregiver-Assisted
9.3.2. Self-Administered
9.4. Hospitals
9.5. Rehabilitation Centers
10. Cardiac Rehabilitation Device Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sales
10.3. Distributor Networks
10.4. Online/e-commerce Platform
11. Cardiac Rehabilitation Device Market, by Region
11.1. Asia-Pacific
11.2. North America
11.3. Latin America
11.4. Europe
11.5. Middle East
11.6. Africa
12. Cardiac Rehabilitation Device Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Cardiac Rehabilitation Device Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. AlivCor Inc.
15.3. Bardy Diagnostics, Inc.
15.4. Berlin Heart GmbH
15.5. BiVACOR Inc.
15.6. Boston Scientific Corporation
15.7. Cardiac Insight, Inc.
15.8. Cardiobridge GmbH
15.9. CorInnova, Inc.
15.10. CorWave SA
15.11. GE HealthCare Technologies Inc.
15.12. Getinge AB
15.13. Hill-Rom Holdings, Inc.
15.14. Jarvik Heart Inc.
15.15. Koninklijke Philips N.V.
15.16. LivaNova PLC
15.17. Medtronic PLC
15.18. OSI Systems, Inc.
15.19. Supira Medical
15.20. Teleflex Incorporated
15.21. Terumo Corporation
15.22. Xenios AG
List of Figures
FIGURE 1. GLOBAL CARDIAC REHABILITATION DEVICE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CARDIAC REHABILITATION DEVICE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CARDIAC REHABILITATION DEVICE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CARDIAC REHABILITATION DEVICE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL CARDIAC REHABILITATION DEVICE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL MONITORING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL MONITORING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL BLOOD PRESSURE MONITORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL BLOOD PRESSURE MONITORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL BLOOD PRESSURE MONITORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL ECG MONITORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL ECG MONITORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL ECG MONITORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL MULTI-PARAMETER MONITORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL MULTI-PARAMETER MONITORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL MULTI-PARAMETER MONITORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL PULSE OXIMETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL PULSE OXIMETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL PULSE OXIMETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL REHABILITATION EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL REHABILITATION EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL REHABILITATION EQUIPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL ARM ERGOMETER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL ARM ERGOMETER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL ARM ERGOMETER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL CYCLE ERGOMETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL CYCLE ERGOMETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CYCLE ERGOMETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL TREADMILLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL TREADMILLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL TREADMILLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL THERAPEUTIC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL THERAPEUTIC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL THERAPEUTIC DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ELECTRICAL STIMULATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ELECTRICAL STIMULATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ELECTRICAL STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL RESPIRATORY THERAPY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL RESPIRATORY THERAPY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL RESPIRATORY THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL ULTRASOUND THERAPY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL ULTRASOUND THERAPY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL ULTRASOUND THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL POST-MYOCARDIAL INFARCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL POST-MYOCARDIAL INFARCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL POST-MYOCARDIAL INFARCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL HEART FAILURE REHABILITATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL HEART FAILURE REHABILITATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL HEART FAILURE REHABILITATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL POST-CORONARY ARTERY BYPASS GRAFT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL POST-CORONARY ARTERY BYPASS GRAFT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL POST-CORONARY ARTERY BYPASS GRAFT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL POST-VALVE REPLACEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL POST-VALVE REPLACEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL POST-VALVE REPLACEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL CARDIAC REHAB CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL CARDIAC REHAB CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL CARDIAC REHAB CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL PHYSICAL THERAPY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL PHYSICAL THERAPY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL PHYSICAL THERAPY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL CAREGIVER-ASSISTED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CAREGIVER-ASSISTED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL CAREGIVER-ASSISTED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL SELF-ADMINISTERED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL SELF-ADMINISTERED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL SELF-ADMINISTERED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL DISTRIBUTOR NETWORKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL DISTRIBUTOR NETWORKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL DISTRIBUTOR NETWORKS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL ONLINE/E-COMMERCE PLATFORM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL ONLINE/E-COMMERCE PLATFORM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL ONLINE/E-COMMERCE PLATFORM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 104. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 105. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 106. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 107. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 108. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 109. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 110. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 111. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 112. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 114. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 115. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 116. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 117. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 118. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 119. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 120. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 121. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 122. EUROPE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. EUROPE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 124. EUROPE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 125. EUROPE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 126. EUROPE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 127. EUROPE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 128. EUROPE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 129. EUROPE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 130. EUROPE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 131. EUROPE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 132. MIDDLE EAST CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. MIDDLE EAST CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 134. MIDDLE EAST CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 135. MIDDLE EAST CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 136. MIDDLE EAST CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 137. MIDDLE EAST CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 138. MIDDLE EAST CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 139. MIDDLE EAST CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 140. MIDDLE EAST CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 141. MIDDLE EAST CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 142. AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 144. AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 145. AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 146. AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 147. AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 148. AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 149. AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 150. AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 151. AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. ASEAN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 154. ASEAN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 155. ASEAN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 156. ASEAN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 157. ASEAN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 158. ASEAN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 159. ASEAN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 160. ASEAN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 161. ASEAN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 162. ASEAN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 163. GCC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 164. GCC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 165. GCC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 166. GCC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 167. GCC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 168. GCC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 169. GCC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 170. GCC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 171. GCC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 172. GCC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION CARDIAC REHABILITATION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 183. BRICS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 184. BRICS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 185. BRICS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 186. BRICS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 187. BRICS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 188. BRICS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 189. BRICS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. BRICS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 191. BRICS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 192. BRICS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 193. G7 CARDIAC REHABILITATION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 194. G7 CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 195. G7 CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 196. G7 CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 197. G7 CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 198. G7 CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 199. G7 CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 200. G7 CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 201. G7 CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 202. G7 CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 203. NATO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 204. NATO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 205. NATO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 206. NATO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 207. NATO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 208. NATO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 209. NATO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 210. NATO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 211. NATO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 212. NATO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 213. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 214. UNITED STATES CARDIAC REHABILITATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 215. UNITED STATES CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 216. UNITED STATES CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 217. UNITED STATES CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 218. UNITED STATES CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 219. UNITED STATES CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 220. UNITED STATES CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 221. UNITED STATES CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 222. UNITED STATES CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 223. UNITED STATES CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 224. CANADA CARDIAC REHABILITATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 225. CANADA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 226. CANADA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 227. CANADA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 228. CANADA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 229. CANADA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 230. CANADA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 231. CANADA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 232. CANADA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 233. CANADA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 234. MEXICO CARDIAC REHABILITATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 235. MEXICO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 236. MEXICO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 237. MEXICO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 238. MEXICO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 239. MEXICO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 240. MEXICO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 241. MEXICO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 242. MEXICO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 243. MEXICO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 244. BRAZIL CARDIAC REHABILITATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 245. BRAZIL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 246. BRAZIL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 247. BRAZIL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 248. BRAZIL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 249. BRAZIL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 250. BRAZIL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 251. BRAZIL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 252. BRAZIL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 253. BRAZIL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 254. UNITED KINGDOM CARDIAC REHABILITATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 255. UNITED KINGDOM CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 256. UNITED KINGDOM CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 257. UNITED KINGDOM CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 258. UNITED KINGDOM CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 259. UNITED KINGDOM CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 260. UNITED KINGDOM CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 261. UNITED KINGDOM CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 262. UNITED KINGDOM CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 263. UNITED KINGDOM CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 264. GERMANY CARDIAC REHABILITATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 265. GERMANY CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 266. GERMANY CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 267. GERMANY CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 268. GERMANY CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 269. GERMANY CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 270. GERMANY CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 271. GERMANY CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 272. GERMANY CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 273. GERMANY CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 274. FRANCE CARDIAC REHABILITATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 275. FRANCE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 276. FRANCE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 277. FRANCE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 278. FRANCE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 279. FRANCE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 280. FRANCE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 281. FRANCE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 282. FRANCE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 283. FRANCE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 284. RUSSIA CARDIAC REHABILITATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 285. RUSSIA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 286. RUSSIA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 287. RUSSIA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 288. RUSSIA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 289. RUSSIA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 290. RUSSIA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 291. RUSSIA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 292. RUSSIA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 293. RUSSIA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 294. ITALY CARDIAC REHABILITATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 295. ITALY CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 296. ITALY CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 297. ITALY CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 298. ITALY CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 299. ITALY CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 300. ITALY CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 301. ITALY CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 302. ITALY CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 303. ITALY CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 304. SPAIN CARDIAC REHABILITATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 305. SPAIN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 306. SPAIN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 307. SPAIN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 308. SPAIN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 309. SPAIN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 310. SPAIN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. SPAIN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 312. SPAIN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 313. SPAIN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 314. CHINA CARDIAC REHABILITATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 315. CHINA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 316. CHINA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 317. CHINA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 318. CHINA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 319. CHINA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 320. CHINA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 321. CHINA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 322. CHINA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2017-2032 (USD MILLION)
TABLE 323. CHINA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 324. INDIA CARDIAC REHABILITATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 325. INDIA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 326. INDIA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE

Companies Mentioned

  • Abbott Laboratories
  • AlivCor Inc.
  • Bardy Diagnostics, Inc.
  • Berlin Heart GmbH
  • BiVACOR Inc.
  • Boston Scientific Corporation
  • Cardiac Insight, Inc.
  • Cardiobridge GmbH
  • CorInnova, Inc.
  • CorWave SA
  • GE HealthCare Technologies Inc.
  • Getinge AB
  • Hill-Rom Holdings, Inc.
  • Jarvik Heart Inc.
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic PLC
  • OSI Systems, Inc.
  • Supira Medical
  • Teleflex Incorporated
  • Terumo Corporation
  • Xenios AG

Table Information